Dual-layer spectral CT for iodine mapping and surrogate perfusion evaluation in cerebrovascular disease - Report - MDSpire

Dual-layer spectral CT for iodine mapping and surrogate perfusion evaluation in cerebrovascular disease

  • By

  • Niclas Schmitt

  • July 16, 2025

  • 0 min

Share

Dual-layer spectral CT for iodine mapping and surrogate perfusion in cerebrovascular disease

Overview

Dual-layer spectral computed tomography (DLCT) enables iodine density mapping as a static surrogate of cerebral perfusion, showing good correlation with conventional cerebral perfusion CT (cCTP) parameters. DLCT offers a potential 39% reduction in radiation dose compared to cCTP, suggesting a promising role in cerebrovascular imaging with reduced radiation exposure.

Background

Cerebral perfusion imaging is essential for managing cerebrovascular diseases such as ischemic stroke and transient ischemic attack by assessing parameters like cerebral blood flow (CBF), cerebral blood volume (CBV), and mean transit time (MTT). Conventional cerebral perfusion CT (cCTP) provides dynamic perfusion data but involves high radiation doses, limiting repeated use. Dual-layer spectral CT (DLCT) can generate iodine density (ID) maps and virtual monochromatic images (VMIs), potentially serving as a static surrogate for perfusion with lower radiation exposure. However, DLCT does not provide time-resolved perfusion parameters, and its clinical utility in cerebrovascular disease requires further evaluation.

Data Highlights

ParameterFinding
Radiation Dose Reduction39% reduction with DLCT iodine mapping vs. cCTP
Correlation of Perfusion ParametersStrong agreement between sCTP and cCTP, especially at 60 keV VMIs
Patient Cohort163 patients with cerebrovascular disorders analyzed retrospectively

Key Findings

  • DLCT iodine density maps correlate well with conventional perfusion parameters such as relative CBF and CBV.
  • Virtual monochromatic images at 60 keV provide optimal agreement between spectral and conventional perfusion CT.
  • DLCT enables a 39% reduction in radiation dose compared to conventional cerebral perfusion CT.
  • ID maps serve as static surrogates for perfusion but lack dynamic parameters like MTT and CBF.
  • DLCT may be particularly useful in patients where CTP is contraindicated or impractical.
  • Single CTA scans with DLCT can assess both vascular status and iodine distribution, potentially streamlining clinical workflows.

Clinical Implications

DLCT offers a lower radiation alternative for cerebral perfusion assessment, which is beneficial for patients requiring repeated imaging such as stroke follow-up or chronic cerebrovascular monitoring. While DLCT iodine maps cannot replace dynamic perfusion parameters essential for acute stroke triage, they provide valuable complementary information and may reduce the need for multiple imaging studies. Integration of DLCT into clinical practice could improve workflow efficiency and patient safety.

Conclusion

DLCT-derived iodine density mapping shows promise as a radiation-sparing surrogate for cerebral perfusion imaging with good correlation to conventional perfusion CT parameters. Further prospective studies are needed to validate its diagnostic accuracy and define its role in cerebrovascular disease management.

References

  1. Liu et al 2023 -- Dual-layer spectral CT for cerebral perfusion assessment
  2. Stiller et al 2020 -- Iodine maps correlate with pancreatic perfusion
  3. Pelgrim et al 2019 -- Myocardial iodine concentration as perfusion marker

Original Source(s)

Related Content